Clinical Trial Update: A Clinical Trial to Assess the Efficacy and Safety of JMT103 in Patients With Refractory HCM [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update for JMT103 evaluating efficacy and safety in patients with refractory hypercalcemia of malignancy (Phase 1/Phase 2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercalcemia of Malignancy

Drugs mentioned

• JMT103

Snippet

Sponsor: Shanghai JMT-Bio Inc. | Conditions: Hypercalcemia of Malignancy | Phase 1, Phase 2 | Status: UNKNOWN